An overview on the seven pathogenic human coronaviruses
- PMID: 34339073
- DOI: 10.1002/rmv.2282
An overview on the seven pathogenic human coronaviruses
Abstract
To date, seven human coronaviruses (HCoVs) have been detected: HCoV-NL63, HCoV-229E, HCoV-HKU1, HCoV-OC43, severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and SARS-CoV-2. Four of these viruses, including HCoV-NL63, -229E, -HKU1 and -OC43, usually cause mild-to-moderate respiratory diseases with a seasonal pattern. Since 2000, three new HCoVs have emerged with a significant mortality rate. Although SARS-CoV and MERS-CoV caused an epidemic in some countries, SARS-CoV-2 escalated into a pandemic. All HCoVs can cause severe complications in the elderly and immunocompromised individuals. The bat origin of HCoVs, the presence of intermediate hosts and the nature of their viral replication suggest that other new coronaviruses may emerge in the future. Despite the fact that all HCoVs share similarities in viral replication, they differ in their accessory proteins, incubation period and pathogenicity. This study aims to review these differences between the seven HCoVs.
Keywords: HCoV-229E; HCoV-HKU1; HCoV-NL63; HCoV-OC43; MERS-CoV; SARS-CoV; SARS-CoV-2; human coronaviruses.
© 2021 John Wiley & Sons Ltd.
Similar articles
-
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.Clin Infect Dis. 2022 Aug 24;75(1):e653-e661. doi: 10.1093/cid/ciac057. Clin Infect Dis. 2022. PMID: 35079775 Free PMC article.
-
Improved Culture Methods for Human Coronaviruses HCoV-OC43, HCoV-229E, and HCoV-NL63.Curr Protoc. 2023 Oct;3(10):e914. doi: 10.1002/cpz1.914. Curr Protoc. 2023. PMID: 37882768 Free PMC article.
-
Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?Front Immunol. 2022 Sep 8;13:954093. doi: 10.3389/fimmu.2022.954093. eCollection 2022. Front Immunol. 2022. PMID: 36159791 Free PMC article.
-
Structural proteins of human coronaviruses: what makes them different?Front Cell Infect Microbiol. 2024 Dec 6;14:1458383. doi: 10.3389/fcimb.2024.1458383. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39711780 Free PMC article. Review.
-
Evolutionary trajectory of SARS-CoV-2 and emerging variants.Virol J. 2021 Aug 13;18(1):166. doi: 10.1186/s12985-021-01633-w. Virol J. 2021. PMID: 34389034 Free PMC article. Review.
Cited by
-
Genomic analysis of the SARS-CoV-2 variants circulated in the Philippines, 2020-2024.Dialogues Health. 2024 Sep 12;5:100193. doi: 10.1016/j.dialog.2024.100193. eCollection 2024 Dec. Dialogues Health. 2024. PMID: 39345340 Free PMC article.
-
Carrimycin inhibits coronavirus replication by decreasing the efficiency of programmed -1 ribosomal frameshifting through directly binding to the RNA pseudoknot of viral frameshift-stimulatory element.Acta Pharm Sin B. 2024 Jun;14(6):2567-2580. doi: 10.1016/j.apsb.2024.02.023. Epub 2024 Mar 3. Acta Pharm Sin B. 2024. PMID: 38828157 Free PMC article.
-
The HCoV-HKU1 N-Terminal Domain Binds a Wide Range of 9-O-Acetylated Sialic Acids Presented on Different Glycan Cores.ACS Infect Dis. 2024 Nov 8;10(11):3880-3890. doi: 10.1021/acsinfecdis.4c00488. Epub 2024 Oct 12. ACS Infect Dis. 2024. PMID: 39394950 Free PMC article.
-
Breaking the Chain: Protease Inhibitors as Game Changers in Respiratory Viruses Management.Int J Mol Sci. 2024 Jul 25;25(15):8105. doi: 10.3390/ijms25158105. Int J Mol Sci. 2024. PMID: 39125676 Free PMC article. Review.
-
Temporary impact on medical system and effectiveness of mitigation strategies after COVID-19 policy adjustment in China: a modeling study.Front Public Health. 2023 Dec 1;11:1259084. doi: 10.3389/fpubh.2023.1259084. eCollection 2023. Front Public Health. 2023. PMID: 38106897 Free PMC article.
References
-
- ICTV. Taxonomy. https://talk.ictvonline.org/taxonomy/
-
- Liu DX, Liang JQ, Fung TS. Human coronavirus-229E, -OC43, -NL63, and -HKU1. Ref Module Life Sci. 2020. https://doi.org/10.1016/B978-0-12-809633-8.21501-X
-
- SARS (10 Years After). https://www.cdc.gov/dotw/sars/index.html
-
- Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). Treasure Island, FL: StatPearls Publishing; 2020.
-
- Navand A, Soltani S, Moghadami M, Hosseini P, Nasimzadeh S, Zandi M. Diabetes and coronavirus infections (SARS-CoV, MERS-CoV, and SARS-CoV-2). J Acute Dis. 2020;9(6):244-247.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous